Discovery of Biomarkers of Resistance to Immune Checkpoint Blockade in NSCLC Using High-Plex Digital Spatial ProfilingMyrto Moutafi, David L. Rimm, Sandra Martínez-Morilla et al.|Journal of Thoracic Oncology|2022Cited by 40
Development of an immunohistochemical assay for Siglec-15Saba Shafi, David L. Rimm, Thazin Nwe Aung et al.|Laboratory Investigation|2022Cited by 13
Supplementary Figure 2 from Association of PD-1/PD-L1 Co-location with Immunotherapy Outcomes in Non–Small Cell Lung CancerNiki Gavrielatou, David L. Rimm, Ioannis Vathiotis et al.|Unknown|2023Cited by 0
Supplementary Figure 1 from Association of PD-1/PD-L1 Co-location with Immunotherapy Outcomes in Non–Small Cell Lung CancerNiki Gavrielatou, David L. Rimm, Yuting Liu et al.|Unknown|2023Cited by 0
Data from Association of PD-1/PD-L1 Co-location with Immunotherapy Outcomes in Non–Small Cell Lung CancerNiki Gavrielatou, David L. Rimm, Yuting Liu et al.|Unknown|2023Cited by 0